2020
DOI: 10.1101/2020.03.10.985614
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Cytotoxic Activity of CD4 T Cells During the Early Stage of Autoimmune Neuroinflammation

Abstract: 1Pathogenic CD4+ T cells are capable of initiating neuroinflammation in experimental 2 autoimmune encephalomyelitis (EAE). However, the precise effector mechanism of these 3 autoaggressive CD4+ T cells is not entirely elucidated. Here, we demonstrated that 4 pathogenic CD4+ T cells, upon autoantigen stimulation, developed a cytotoxic phenotype at 5 the onset of EAE. The cytotoxic activity of pathogenic CD4+ T cells was sufficient to explain 6 the initial myelin lesion. Consistently, CD4+ T cells of peripheral … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…Interestingly, we observed that the expression (raw counts) of CD28 mRNA was generally low, especially in cells with high expression of GZMB in Th17-polarized cells in coculture with OLs by single-cell RNA sequencing ( Supplementary Figure 9B ). Granzyme B levels are elevated in the CSF of MS patients ( 42 ) and CD4 + T cells from MS patients secrete more granzyme B than healthy controls in the relapsing–remitting ( 85 ) and progressive forms ( 86 ). In addition, pro-inflammatory CD4 + T cells secreting granzyme B can disrupt the blood–brain barrier ( 87 ) and cause glial fibrillary acid protein fragmentation in human primary astrocytes in vitro ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, we observed that the expression (raw counts) of CD28 mRNA was generally low, especially in cells with high expression of GZMB in Th17-polarized cells in coculture with OLs by single-cell RNA sequencing ( Supplementary Figure 9B ). Granzyme B levels are elevated in the CSF of MS patients ( 42 ) and CD4 + T cells from MS patients secrete more granzyme B than healthy controls in the relapsing–remitting ( 85 ) and progressive forms ( 86 ). In addition, pro-inflammatory CD4 + T cells secreting granzyme B can disrupt the blood–brain barrier ( 87 ) and cause glial fibrillary acid protein fragmentation in human primary astrocytes in vitro ( 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…Here, we provide evidence of cytotoxic behavior derived from CD3+CD20+ T cell during progressive MS. Recently, we demonstrated that, despite not known as a classical cytotoxic subset, the ectopic expression of GzmB by CD4+ T cells is increased in the peripheral blood from RRMS patients particularly during Natalizumab treatment when compared to other MS therapies, untreated MS patients and healthy donors (Pradella et al, 2020). Importantly, classical CD8+GzmB+ and ectopic CD4+GzmB+ T cells were shown into CNS-lesions from fulminant MS relapses after Natalizumab discontinuation (Larochelle et al, 2017;Serafini et al, 2017).…”
Section: Discussionmentioning
confidence: 92%
“…Perforin-and serine protease granzyme-B (GzmB)-derived circulating CD8+ and CD4+ T lymphocytes from MS patients were previously identified (Broux et al, 2015;Cencioni et al, 2017;Fujii et al, 2016;Pradella et al, 2020). However, this cytotoxic behavior was not yet investigated in CD3+CD20+ T cells from MS patients.…”
Section: Expression Of Perforin and Serine-protease Granzyme-b (Gzmb)...mentioning
confidence: 99%
“…While these findings supported the idea that CD4 + T cells responding to Myhc-α 334-352 may possess the characteristics of cytotoxic CD4 + T cells, we sought to further validate them by testing the expression of other newly described markers of CD4 + CTLs. These included surface expression of NKG2A [50], NKG2D [51], and CRTAM [52] and intracellular expression of EOMES [53][54][55]. In a flow cytometric analysis, we compared the expression of CD107a with that of NKG2A, NKG2D, CRTAM, and EOMES, expecting to find that their detection aligned with CD107a expression.…”
Section: Resultsmentioning
confidence: 99%